Artificial endocrinal gland

• US 4,253,456 A
• Filed: 08/21/1978
• Issued: 03/03/1981
• Est. Priority Date: 08/23/1977
• Status: Expired due to Term

• Current Assignee: Dr Eduard Fresenius Chemisch-Pharmazeutische Industrie KG Apparatebau KG
• Original Assignee: Dr Eduard Fresenius Chemisch-Pharmazeutische Industrie KG Apparatebau KG
• Inventors: Schindler, Johannes G., Schal, Wilfred
• Primary Examiner(s): HOWELL, KYLE
• Application Number:
  US05/935,600
• Time in Patent Office: 925 Days
• Field of Search: 128/213 R, 128/213 A, 128/214 R, 128/214 B, 128/214 E, 128/DIG. 12, 128/DIG. 13, 128/DIG. 3, 128/632-637, 422/44, 422/48, 422/45, 210/321 B, 210/96.1, 210/96.2, 210/22
• US Class Current: 604/31
• CPC Class Codes: A61M 1/1678 intracorporal peritoneal dialysis A61M1/28
• CPC Class Codes: A61M 1/36 Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: F04B 43/1215 having no backing plate (deforming of the tube only by rollers)
• CPC Class Codes: Y10S 128/13 Infusion monitoring

Abstract

An artificial endocrinal gland comprises a blood dialyzer for transferring part of the blood to a measuring liquid in a separate circuit, an analyzer for quantatively determining this part and producing in the measuring liquid conversion products compatible to the patient'"'"'s metabolism, a controller responsive to the analyzer and a device for supplying quantities of hormone to the patient'"'"'s body under the control of the controller.

Claims

1. A system intended for use in a patient for simulating an endocrinal gland by transferring a component of the flowing blood from said patient being monitored and treated into a measuring fluid flow path, comprising:

(a) means for providing a constant flow of measuring fluid in a closed path, said measuring fluid not being consumed or diluted during measurement in said measuring fluid flow path;

(b) dialyzing means coupled to said flowing blood and having a semipermeable membrane, said membrane permitting a component of said blood being monitored to be transferred to said measuring fluid in said measuring fluid flow path;

(c) reactor means serially disposed in said measuring fluid flow path, said reactor means containing a compound in immobilized form for catalytic conversion of said component of said blood to be transferred to said measuring fluid flow path;

(d) analyzer means serially coupled in said measuring fluid flow path for quantatatively determining the amount of said component of blood, said analyzer conversion products produced and appearing in said measuring fluid being compatable with the metabolism of said patient;

(e) means coupled into said blood being monitored for supplying a material into said blood to modify the amount of said component appearing in said blood; and

(f) controller means responsive to said analyzer means for controlling the quantity of said material supplied by said supplying means.

2. A system for simulating an endrocrinal gland according to claim 1 wherein said reactor means comprises an enzyme reactor and said compound for catalytic conversion comprises an enzyme bonded at the surface of a polymeric carrier material.

3. A system for simulating an endocrinal gland according to claim 1 further including a switching means coupled in said measuring fluid flow path for providing periodic calibration of said analyzer means with a calibration liquid while blocking off circulation of said measuring fluid flow path

4. A system for simulating an endocrinal gland according to claim 3, wherein said means for providing a constant circulation of said measuring fluid includes pump means, said pump means being activated by a motor, said motor also controlling said switching means provided in said fluid flow path.

5. A system for simulating an endocrinal gland according to claim 1 further including optical monitoring devices for detecting blood in the measuring fluid and air in the fluid returned into said monitored blood.

6. A system for simulating an endocrinal gland according to claim 5 wherein said gland is a pancreas beta cell and said measuring fluid flow path includes an oxygenator, an enzyme reactor and an oxygen sensitive measuring probe arranged serially in said measuring fluid path.

7. A system for simulating an endocrinal gland according to claim 6 wherein said oxyginator is constructed as a roller pump with hoses for simultaneously permitting the passage of oxygen from the surrounding air into said measuring fluid by mechanical agitation of said hoses and circulating said measuring fluid in said closed measuring fluid flow path.

8. A system intended for use in a patient for simulating an endocrinal gland by transferring a component of the flowing blood from said patient being monitored and treated into a measuring fluid flow path comprising:

(a) dialyzing means coupled to said flowing blood and having a semipermeable membrane, said membrane permitting a component of said blood being monitored to be transferred to said measuring fluid in said measuring fluid flow path;

(b) said measuring fluid flow path forming a closed path in which said measuring fluid is recirculating without any consumption of measuring fluid and is blocked off from any additional liquid supplied during measurement,

said closed measuring path including;

(i) means for providing a constant circulation of measuring fluid flow,

(ii) reactor means serially coupled in said measuring fluid flow path, said reactor means containing a compound for catalytic conversion of said blood component to be transferred to said measuring fluid flow path, said compound being in immobilized form, and

(iii) analyzer means serially coupled in said measuring fluid flow path for quantitatively determining the amount of said component of said blood within said measuring fluid flow path;

(c) means coupled into said blood being monitored for supplying a material into said blood to modify the amount of said component of said blood being transferred to said measuring fluid flow path; and

(d) controller means responsive to said analyzer means for controlling the quantity of said material supplied by said supplying means.

9. A system for simulating an endocrinal gland according to claim 8 wherein said quantitatively determining means includes a catalytic conversion of said component of said blood.

10. A system intended for use in a patient for simulating an endocrinal gland by transferring a component of the flowing blood from said patient being monitored and treated into a measuring fluid flow path comprising:

(a) means for providing a constant flow of measuring fluid in a closed path, said measuring fluid not being consumed or diluted during measurement in said measuring fluid flow path;

(b) dialyzing means coupled to said flowing blood and having a semipermeable membrane, said membrane permitting a component of said blood being monitored to be transferred to said measuring fluid in said measuring fluid flow path;

(c) reactor means serially coupled in said measuring fluid flow path, said reactor means containing a compound in immobilized form for catalytic conversion of said component of said blood to be transferred to said measuring fluid flow path; and

(d) analyzer means serially coupled in said measuring fluid flow path for quantitatively determining the amount of said component of blood, said analyzer conversion products produced and appearing in aid meausring fluid being compatible with the metabolism of said patient.

11. A system for simulating an endocrinal gland according to claim 10 further including:

(d) means coupled in said blood being monitored for supplying a material into said blood to modify the amount of said component appearing in said blood; and

(e) controller means responsive to said analyzer means for controlling the quantity of said material supplied by said supplying means.